These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 4342755

  • 21. [Experience with depot neuroleptics].
    Arató M, Erdós A.
    Orv Hetil; 1979 Apr 29; 120(17):1015-21. PubMed ID: 372888
    [No Abstract] [Full Text] [Related]

  • 22. [Therapeutic management, the hospital environment].
    Gayral L.
    Encephale; 1970 Apr 29; ():Suppl:19-25. PubMed ID: 5458709
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Dosage and side effect comparisons betweel oral and depot fluphenazine.
    Schooler NR, Levine J.
    Psychopharmacol Bull; 1977 Jul 29; 13(3):29-31. PubMed ID: 329328
    [No Abstract] [Full Text] [Related]

  • 26. Fluphenazine outpatient clinics: a pharmacist's role.
    Bond CA, Salinger RJ.
    J Clin Psychiatry; 1979 Dec 29; 40(12):501-3. PubMed ID: 500572
    [Abstract] [Full Text] [Related]

  • 27. Long-acting phenothiazines for treatment of schizophrenia.
    Med Lett Drugs Ther; 1976 Jan 16; 18(2):6-7. PubMed ID: 1107791
    [No Abstract] [Full Text] [Related]

  • 28. [The position of the depot-neuroleptics in the therapy of chronic psychoses. Experience with fluphenazine-decanoate].
    Auch W.
    Med Welt; 1970 Oct 10; 21(41):1785-8. PubMed ID: 5471981
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The use of fluphenazine decanoate (Modecate)depot therapy in outpatient schizophrenics-a retrospective study.
    Tan CT, Ong TC, Chee KT.
    Singapore Med J; 1981 Aug 10; 22(4):214-8. PubMed ID: 7323829
    [No Abstract] [Full Text] [Related]

  • 31. [Neuroleptic infusion therapy with high-dosed fluphenazine (author's transl)].
    Fünfgeld EW, Kulhanek F.
    Arzneimittelforschung; 1978 Aug 10; 28(9):1489-91. PubMed ID: 383096
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Trial of delayed-action neuroleptics in the treatment of acute psychotic conditions].
    Gayral L, Escande M, Fournié H, Perretti A.
    Ann Med Psychol (Paris); 1972 Mar 10; 1(3):381-94. PubMed ID: 5053751
    [No Abstract] [Full Text] [Related]

  • 36. Depot fluphenazine in the prevention of relapse in schizophrenia: evaluation of a treatment regimen [proceedings].
    Schooler NR, Levine J, Severe JB.
    Psychopharmacol Bull; 1979 Apr 10; 15(2):44-7. PubMed ID: 373006
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Clinical significance of depot fluphenazine decanoate in therapy of acute psychotic disorders].
    Ngui PW.
    Seishin Shinkeigaku Zasshi; 1983 Apr 10; 85(9):635-9. PubMed ID: 6676769
    [No Abstract] [Full Text] [Related]

  • 40. [Prolonged treatment of schizophrenic psychoses with depot-fluphenazine ("lyogen decanoate")].
    Bohacek N, Mihovilović M.
    Neuropsihijatrija; 1968 Apr 10; 16(3):69-73. PubMed ID: 5195835
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.